Revenue: Not reported for QQ3 2025 (quarterly revenue field is null; where disclosed, quarterly revenue in select earlier quarters included amounts such as $54,592 in Q4 2024). Gross Profit: -$9,099 with no explicit gross margin reported; YoY change listed as 0.00% and QoQ 0.01% in the dataset. Operating Income: -$343,265; YoY change -6.26%; QoQ change +6.54%. Net Income: -$531,555; YoY change -26.96%; QoQ change -12.75%. EBITDA: -$318,401. EPS: -$0.0001; diluted EPS: -$0.0001.
Liquidity and leverage indicators show: current ratio 0.00097, quick ratio 0.00097, cash ratio 0, total debt $2,481,241, and net debt $2,481,241. Total assets $1,020,113 vs total liabilities $6,161,764, resulting in negative stockholders’ equity of $-5,141,651. CFO/OCF: -$114,520; net change in cash -$6,913; financing activities contributed +$107,607. Free cash flow: -$114,520.
Balance sheet highlights: PPE net of $1,014,113; total current assets $6,000; total current liabilities $6,161,764; total assets $1,020,113; total liabilities and stockholders’ equity $1,020,113. These metrics imply acute liquidity stress and a balance sheet skewed toward heavy liabilities relative to assets.